Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma

Masanori Murakami(Tokyo Medical and Dental University), Felix Beuschlein(University of Zurich), Thomas Kirchner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christian Greunke(Helmholtz Munich), Martin Faßnacht(University of Würzburg), Martín Reincke(LMU Klinikum), Stefan Kircher(University of Freiburg), Na Sun(Max Planck Institute of Biochemistry), Mirko Peitzsch(University Hospital Carl Gustav Carus), Esther Korpershoek(Radboud University Nijmegen), Annette Feuchtinger(Helmholtz Zentrum München), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Matthias Kroiß, Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Letizia Canu(Azienda Ospedaliero-Universitaria Careggi), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Ronald R. de Krijger(University Medical Center Utrecht), Achim Weber(University Hospital of Zurich), Thomas Papathomas(NIHR Birmingham Biomedical Research Centre), Thomas Knösel(LMU Klinikum), Axel Walch(Unknown), Juliane Friemel(University Hospital of Zurich), Paal W. Wallace(University Hospital Carl Gustav Carus), Timo Deutschbein(Klinikum Oldenburg)
European Journal of Endocrinology
May 13, 2021
Cited by 18


Related Papers